IOL Chemicals

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE485C01029
  • NSEID: IOLCP
  • BSEID: 524164
INR
74.26
1.43 (1.96%)
BSENSE

Mar 20

BSE+NSE Vol: 15.86 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Net Sales
1,699.61
1,551.43
1,628.87
1,629.90
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
1,699.61
1,551.43
1,628.87
1,629.90
Raw Material Cost
1,099.95
1,010.73
1,085.75
1,138.11
Purchase of Finished goods
0.19
0.00
0.15
29.22
(Increase) / Decrease In Stocks
14.70
35.33
-11.47
2.10
Employee Cost
177.93
164.18
151.37
126.19
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
Other Expenses
230.34
201.64
222.00
203.91
Total Expenditure (Excl Depreciation)
1,523.11
1,411.88
1,447.80
1,499.53
Operating Profit (PBDIT) excl Other Income
176.50
139.55
181.07
130.37
Other Income
19.54
17.88
22.55
16.88
Operating Profit (PBDIT)
196.04
157.43
203.62
147.25
Interest
11.34
10.73
12.69
11.59
Exceptional Items
-11.21
0.00
0.00
0.00
Gross Profit (PBDT)
173.49
146.70
190.93
135.66
Depreciation
59.94
53.44
46.48
34.05
Profit Before Tax
113.55
93.26
144.45
101.61
Tax
29.07
23.61
37.64
27.25
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
84.48
69.65
106.81
74.36
Extraordinary Items
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
84.48
69.65
106.81
74.36
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
84.48
69.65
106.81
74.36
Equity Capital
58.71
58.71
58.71
58.71
Face Value
2.0
10.0
10.0
10.0
Reserves
1,713.32
1,620.99
1,554.22
1,406.95
Diluted Earnings per share
0.7
0.7
3.93
4.05
Operating Profit Margin (Excl OI)
10.38%
8.99%
11.12%
8.0%
Gross Profit Margin
10.21%
9.46%
11.72%
8.32%
PAT Margin
4.97%
4.49%
6.56%
4.56%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 9.55% vs -4.75% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 21.29% vs -34.79% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 26.48% vs -22.93% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 5.68% vs -15.45% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of IOL Chemicals With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,699.61
1,626.73
72.88
4.48%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,699.61
1,626.73
72.88
4.48%
Raw Material Cost
1,099.95
584.80
515.15
88.09%
Purchase of Finished goods
0.19
139.70
-139.51
-99.86%
(Increase) / Decrease In Stocks
14.70
28.03
-13.33
-47.56%
Employee Cost
177.93
306.82
-128.89
-42.01%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
230.34
433.93
-203.59
-46.92%
Total Expenditure (Excl Depreciation)
1,523.11
1,493.28
29.83
2.00%
Operating Profit (PBDIT) excl Other Income
176.50
133.45
43.05
32.26%
Other Income
19.54
39.59
-20.05
-50.64%
Operating Profit (PBDIT)
196.04
173.04
23.00
13.29%
Interest
11.34
22.20
-10.86
-48.92%
Exceptional Items
-11.21
217.26
-228.47
-105.16%
Gross Profit (PBDT)
173.49
368.10
-194.61
-52.87%
Depreciation
59.94
94.51
-34.57
-36.58%
Profit Before Tax
113.55
273.59
-160.04
-58.50%
Tax
29.07
31.66
-2.59
-8.18%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
84.48
241.93
-157.45
-65.08%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
84.48
241.93
-157.45
-65.08%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
84.48
241.93
-157.45
-65.08%
Equity Capital
58.71
14.08
44.63
316.97%
Face Value
2.00
2.00
0.00
Reserves
1,713.32
0.00
1,713.32
Gross Profit Margin
10.21%
22.63%
0.00
-12.42%
PAT Margin
4.97%
14.87%
0.00
-9.90%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,699.61 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 9.55% vs -4.75% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 84.48 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 21.29% vs -34.79% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 176.50 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 26.48% vs -22.93% in Dec 2024

Nine Monthly - Interest
Interest 11.34 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 5.68% vs -15.45% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.38%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024